RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Plexiform Neurofibroma Treated with Pharmacopuncture

      한글로보기

      https://www.riss.kr/link?id=A103900922

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objectives: The purpose of this study is to report a case of a plexiform neurofibroma (PNF) in the pelvic region treated with sweet bee venom (SBV) and mountain ginseng pharmacopuncture (MGP). Methods: A 16-year-old girl was diagnosed as having PNFs,...

      Objectives: The purpose of this study is to report a case of a plexiform neurofibroma (PNF) in the pelvic region treated with sweet bee venom (SBV) and mountain ginseng pharmacopuncture (MGP).
      Methods: A 16-year-old girl was diagnosed as having PNFs, neurofibromatosis type 1, 10 years ago and she had surgery three times to remove the benign tumors, but the growth of the PNFs continued. She has been treated in our clinic with SBV and MGP two times per month from March 2010 to April 2014. SBV was injected intra-subcutaneously at the borders of the PNFs in the pelvic region, and MGP was administrated intravenously each treatment time.
      Results: The growths of the PNFs occurred rapidly and continued steadily before treatment. Since March 2010, she has been treated in our clinic, and the growths of the PNFs have almost stopped; further-more, the discomfort of hip joint pain has been reduced, and her general condition has improved.
      Conclusion: We cautiously conclude that SBV and MGP treatment has some effects that suppress the growth and the spread of the PNFs in this patient.

      더보기

      참고문헌 (Reference)

      1 Friedrich RE., "Resection of small plexiform neurofibromas in neurofibromatosis type 1 children" 3 (3): 6-, 2005

      2 Sehgal VN., "PlexiformPlexiform neurofibromas in neurofibromatosis type 1" 48 (48): 971-974, 2009

      3 Korf BR., "Plexiform neurofibromas" 89 (89): 31-37, 1999

      4 Momoh JT., "Plexiform neurofibroma in children" 63 (63): 334-338, 1986

      5 Korean Pharmacopuncture Institute, "Pharmacopuncturology:principles and clinical applications" Chapter 09 147-179, 2012

      6 Woodruff JM., "Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis" 89 (89): 23-30, 1999

      7 "Neurofibromatosis. conference statement. national institutes of health consensus development conference" 45 (45): 575-578, 1988

      8 Dugoff L., "Neurofibromatosis type 1 and pregnancy" 66 (66): 7-10, 1996

      9 Samii M., "Neurofibromatosis neurosurgical treatment and follow up" (2) : 14-16, 2007

      10 Donner TR., "Neural sheath tumors of major nerves" 81 (81): 362-373, 1994

      1 Friedrich RE., "Resection of small plexiform neurofibromas in neurofibromatosis type 1 children" 3 (3): 6-, 2005

      2 Sehgal VN., "PlexiformPlexiform neurofibromas in neurofibromatosis type 1" 48 (48): 971-974, 2009

      3 Korf BR., "Plexiform neurofibromas" 89 (89): 31-37, 1999

      4 Momoh JT., "Plexiform neurofibroma in children" 63 (63): 334-338, 1986

      5 Korean Pharmacopuncture Institute, "Pharmacopuncturology:principles and clinical applications" Chapter 09 147-179, 2012

      6 Woodruff JM., "Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis" 89 (89): 23-30, 1999

      7 "Neurofibromatosis. conference statement. national institutes of health consensus development conference" 45 (45): 575-578, 1988

      8 Dugoff L., "Neurofibromatosis type 1 and pregnancy" 66 (66): 7-10, 1996

      9 Samii M., "Neurofibromatosis neurosurgical treatment and follow up" (2) : 14-16, 2007

      10 Donner TR., "Neural sheath tumors of major nerves" 81 (81): 362-373, 1994

      11 Hope DG., "Malignancy in neurofibromatosis" 29 : 33-56, 1981

      12 Sehgal VN., "Evaluation of plexiform neurofibroma in neurofibromatosis type 1 in 18 family members of 3 generations : ultrasonography and magnetic resonance imaging a diagnostic supplement" 48 (48): 275-279, 2009

      13 Tonsgard JH., "Clinical manifestations and management of neurofibromatosis type 1" 13 (13): 2-7, 2006

      14 Cebesoy O., "A case of isolated giant plexiform neurofibroma involving all branches of the common peroneal nerve" 127 (127): 709-712, 2007

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2016-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2015-12-01 평가 등재후보로 하락 (기타) KCI등재후보
      2013-08-01 학술지명변경 한글명 : 대한약침학회지 -> Journal of Pharmacopuncture KCI등재
      2011-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-05-13 학술지명변경 외국어명 : 미등록 -> Journal of Pharmacopuncture KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-07-06 학회명변경 영문명 : Korean Institute of Herbal Acupuncture -> Korean Pharmacopuncture Institute KCI등재후보
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.2 0.2 0.27
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.28 0.29 0.429 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼